|
1.-Terry TL. Extreme prematuruty and fibroblastic overgrowth of persistent
vascular sheath behind each crystalline lens:I. Preliminary report. Am.J.
Ophtalmol 1942; 25:203-204.
2.-Committee for the Classification
of Retinopathy of Prematurity. An International Classification of
Retinopathy of Prematurity. Arch Ophtalmol 1984;106:471-479.
3.-Cryotherapy for retinopathy of
prematurity Cooperative Group. Multicenter trial of cryotherapy
for retinopathy of prematurity:Preliminary
results. Arch Ophtalmol 1988;106:471-479.
4.-Contemporary Understanding and
Management of Retinopathy of Prematurity. Franco M. Recchia, MD, Antonio Capone, JR.,MD.
Retina, Vol 24, 2: 283-292.
5.- The STOP-ROP Multicenter Study
Group. Suplemental Terapeutic
oxygen for prethreshold retinopathy of
prematurity, a randomized, controlled trial:I. Primary outcomes, Pediatrics 2000;105:295-310.
6.- Norrie's disease gene mutations and
retinopathy of prematurity; a real association ? J.Talks,
A.Kychenthal, X.Katz, P.Dorta, G.G.W.Adams, P.Hykin
ARVO Meeting, Fort Lauderdale, Florida, USA, May 1999.
7.- Are mutations of the Norrie's
disease gene associated with retinopathy of prematurity?. J.Talks, A.Kychenthal, X.Katz, P.Dorta, G.G.W.Adams,
P.Hykin. Oxford Ophthalmologic Congress, UK,
1999.
8.-Shastry BS, Pendergast SD, Hartzer
MK, et al. Identification of missense mutations
in the Norrie Disease gene associated in patients with advanced ROP. Arch Ophtalmol
1997;115(5):651-655.
9.-Noyola DE, Bohra l, Payse EA, et al . Associations of candidemia
and retiniphaty of prematurity in very low birth-
weight infants. Ophtalmology 2002;109:80-84.
10.-Reynods JD, Hardy RJ, Kennedy
KA, et al. Lack of efficacy of light reduction in preventing retinopathy of
prematurity: Light reduction in retinopathy of prematurity (LIGHT-ROP)
study group. N Engl J Med 1998;
338(22):1572-1576.
11.-Characteristics of Infants With
Severe Retinopathy of Prematurity in Countries with Low, Moderate, and High
level of development: Implications for scrrening
programs. Clare Gilbert, Alistair Fielder, Luz Gordillo,
Graham Quinn, Renato Semiglia,
Patricia Visintin, Andrea Zin
ando n behalf of the Internacional
NO-ROP group. Pediatrics 2005;115;518-525;
originally published online Apr 1, 2005; DOI: 10.1542/peds.2004-1180.
12.-Evidenc-Based Screening Criteria
for Retinopathy of Prematurity. Natural History data from the Cryo- ROP and Ligh-ROP
Studies. For the Cryo-ROP and Ligh-ROP
Cooperative Groups. Arch. Ophtalmol.2002;120:1470-1476.
13.- Retinopathy of Prematurity: clinical
characteristics and outcome in zone I and II. P. Dorta, X. Katz. A,
Kychenthal. Panamerican Academy of Ophthalmology.
Orlando, Florida, USA, October 1999.
14.-
Gilbert C, Cánovas R, Kocksch
R, Foster A: Ceguera infantil
en Chile. Arch Chil Oftal
1993; 50: 49-53.
15.-
Outcome after laser and surgical treatment for retinopathy of prematurity
((A. Kychenthal B., X. Katz V., P. Dorta S.)) Clínica
Alemana de Santiago; Clínica Las Condes; Hospital del Salvador, Santiago,
Chile, Fort Lauderdale, Florida, USA, ARVO May,2000.
16.-
Revised Indications for the treatment of retinopathy of prematurity.
Results of the Early Treatment for retinopathy of prematurity Randomized
Trial. Arch Ophthalmol.2003;121:1684-1696.
17.- An
International Classification of Retinopathy of Prematurity. II.The classification of retinal detachment. The
International Comitteefor the Classification of
the late stages of retinopathy of prematurity. Arch Ophthalmol-Vol
105: 906-912,July1987.
18.- Adult
Retinopathy of prematurity. Outcomes of Rhegmatogenous
Retinal Detachments and retinal Tears. Richard S. Kaiser,MD, Michael T. Trese,
MD, Geoege A. Williams, MD, Morton S. Cox, JR.,
MD. Ophthalmology 2001;108:1647-1653.
19.-Follow-up study on premature
infants with and without retinophaty of
prematurity. Rosemary Robinson, Michael OKeefe.
Br J Ophthalmol 1993;77:91-94
20.-
Development of myopia in Infants with birth weights less than 1251 grams. Graam E. Quinn, MD, Velma Dobson, PhD, Michael X. Repka, MD, et al on behalf of the cryotherapy
for retinopathy of prematuruty cooperative group.
Ophthalmology 1992;99:329-340.
21.-Cataracts Extraction in Adults With retinopathy of Prematurity.
Thaddeus J. Krolicki, MD, William Tasman, MD.
Arch Ophthalmol.1995;113:173-177.
22.-Multicenter Trial Of Cryotherapy for Retinopathy of Prematurity. Three month
outcome. Cryotherapy for Retinopathy of
prematurity cooperative group. Arch Ophthalmol-vol
108, Feb 1990.
23.-Multicenter Trial of Cryotherapy for Retinopathy of Prematuruty.
One-Year Outcome-Structure and Function. Cryotherapy
for Retinopathy of prematurity cooperative group. Arch Ophthalmol-vol
108, Oct 1990.
24.-Incidence and early course of
Retinopathy of Prematurity. Earl A. Palmer, MD, John T Flynn, MD…The Cryotherapy For Retinopathy of Prematurity Cooperative
Group. Ophthalmology 1991;98:1628-1640.
25.- Zone I
Retinopathy of prematurity: Is a subclassification
necessary?
A. Kychenthal, X. Katz, P. Dorta. American Academy of Ophthalmology.
Orlando, Florida, USA, October 1999.
26.-
Prognostic factors in the natural Course of Retinophaty
of Prematurity. David B. Schaffer,MD, Earl A.
Palmer, MD, on behalf of the Criotherapy of
retinopathy of prematurity Cooperative Group. Ophthalmology 1993;100:230-237.
27.-
Cochrane Database Syst Rev. 2003;(3):CD003665.
Vitamin E supplementation for prevention of morbidity and mortality in
preterm infants. Brion LP, Bell EF, Raghuveer TS.
28.-Multicenter Trial of Cryotherapy for Retinopathy of Prematurity 3 ½-Year Outcome-Structure and Function.Criotherapy
for Retinopathy of Prematurity Cooperative Group.Arch
Ophthalmol-111, March 1993.
29.-
Multicenter Trial of Cryotherapy for Retinopathy
of Prematurity Snellen Visual Acuty
and Structural Outcome at 5 ½-Year after randomizatiom.
Criotherapy for Retinopathy of Prematurity
Cooperative Group.Arch Ophthalmol
1996;114:417-424.
30.-Effect of Retinal Ablative
Therapy for threshold Retinopathy of Prematurity: results of Goldmand Perimetry at age 10
year. Criotherapy for Retinopathy of Prematurity
Cooperative Group.
31.- Multicenter Trial of Cryotherapy for Retinopathy of Prematurity:
Ophthalmological Outcomes at 10 years.Criotherapy
for Retinopathy of Prematurity Cooperative Group.Arch
Ophthalmol 2001 Aug;119(8):1110-8
32.-Does Cryotherapy
Affect refractive errors? Results from treated vs
control eyes in the criotherapy for retinophaty of prematurity Trial. Criotherapy
for Retinopathy of Prematurity Cooperative Group.Present
in part at the annual meeting of The association for Research in Vision and
Ophthalmology, may 14,1998, Fort Lauderdale, florida.
33.-Knight-Nanan MD, OKeefe M. Refractive outcome in eyes with retinophaty of prematurity treated with cryotherapy or diode laser-3years follow up. British
Journal of Ophthalmology 1996;80:998-1001.
34.-Partial Retinal detachment at 3
Months After Threshold Retinopathy of Prematurity. Long-Term Structural and
functional Outcome. Williams S. Gilbert, MD; Graham E. Quinn, MD…for the
multicenter Trial opf Retinipathy
of Prematurity Cooperative Group. Arch Ophthalmol.1996;114:1085-1091.
35.-Zone I RetinopaTHY
OF Prematurity. M.J.Shapiro, J.P.Gieser,
K.A. Warren, K.I. Resnick and N.P. Blair.
Retinopathy of prematurity,pp.149-155. Proceedings
of the International Conference on Retinopathy of Prematurity, Chicago, IL,
USA. November 18-19,1993.
36.-Retinopathy of Prematurity and
Anterior Segment Complications. Michael S. Ibarra, MD, Antonio Capone, Jr, MD. Ophthalmol Clin N Am 17 (2004) 577-582
37.-Threshold Retinopathy of
Prematurity Revised. William Tasman, MD. Editorial Arch. Ophthalmol-Vol 110,May 1992.
38.-Early Treatment of Posterior
Retinopathy of Prematurity. A Controlled Trial. James Vander, MD, James Handa, MD, J. Arch McNamara, MD, Michael Trese, MD, Rand Spencer, MD, Michael X. Repka, MD, Patrick Rubsamen,
MD, Helen Li, MD, Lawrence S. Morse, MD, PhD, William S. Tasman, MD.
Ophthalmology 1997;104:1731-1736.
39.-Threshold Retinopathy of
Prematurity. Transition from Cryopexy to Laser
treatment. Mark E. Hammer, MD, Thomas J. Pusateri,
MD, J. Bruce Hess, MD, Roberto Sosa, MD, Carine Stromquist, MD. Retina 15: 486-489, 1995.
40.-Ng EY, Connolly BP, McNamara JA,
et al. A comparison of laser fotocoagulation with
cryotherapy for threshold retinopathy of
prematurity at 10 years: Part 1. Visual function and structural outcome.
Ophthalmology 2002;109(5):928-934.
41.-Lens-Sparing Vitrectomy for stage 4
Retinopathy of prematurity. G. Baker Hubbard III, MD, D. Hunter Cherwick, MD, Gabriela Burian,
MD, MPH. Ophthalmology 2004;111:2274-2277
42.- Visual
Outcomes after Lens-Sparing Vitrectomy for Stage
4A Retinopathy of Prematuruty. Jonathan
L. Prenner, MD, Antonio Capone, Jr, MD, Michael Tese, MD. Ophthalmology 2004;111:2271-2273.
43.- Effect
of triamcinolona acetonido
on proliferation of retinal endothelial cells in vitro and in vivo. Spandau
UH, Sauder, Schubert U, Hammes HP, Jonas JB.Bj Ophthalmol 2005 Jun;89(6):745-747.
44.-Advanced Retinopathy of
prematurity. The anatomic and visual results of vitreus
Surgery. John D. Zilis, MD, Eugene de Juan, MD,
Robert Machemer, MD. Ophthalmology 1990;97:821-826.
45.- Rhegmatogenous Retinal Detachment following Cryotherapy in Retinophaty of
prematurity. Craig M. Greven,MD,
William Tasman, MD.Arch Ophthalmol.
1989;107:1017-1018.
46.-Visual Acuity in infants after vitrectomy for severe retinopathy of prematurity. Graham
E. Quinn,MDm Velma Dobson, PhD, Charles C. Barr,
MD, Barry R. Davis, MD, PhD, John T. Flynn, MD, Earl A. Palmer, MD, Joseph
Robertson, MD, Michael T. Trese, MD.
Ophthalmology 1991;98:5-13.
47.- Diode laser photocoagulation to the vascular
retina for progressively advancing retinopathy of prematurity. Michael O
Keefe, John Burke, Kais Algawi, Michael Goggin. Br. Jouirnal Ophthalmol 1995;79:1012-1014.
48.-Clinical characteristics and
outcomes after laser and surgical therapy for zone I and II retinopathy of
prematurity. Andres Kychenthal MD, Paola Dorta MD, Ximena
Katz MD.3er Euroretina Congress Hamburg (Germany)
15-17 May 2003.
49.-Anestesia general para prematuros con retinopatía y alta
ntes de 36 horas. Eberhard
Ma E, Kychenthal A, Dorta P, Abarca M. Revista
Chilena de anestesia, vol 33, n 2, Nov 2004.
50.- The
international Classification of Retinopathy of Prematurity Revisited.
An International Committee for the Classification of Retinopathy of
Prematurity, Arch Ophtalmol. 2005;123:991-999
51.-
Efficacy of intravitreal bevacizumab for
stage 3+ retinopathy of prematurity.
Mintz-Hittner HA, Kennedy KA, Chuang AZ; BEAT-ROP
Cooperative Group.
N Engl
J Med. 2011 Feb 17;364(7):603-15. doi: 10.1056/NEJMoa1007374.
52.-
Treatment of type 1
retinopathy of prematurity with intravitreal bevacizumab (Avastin).
Dorta P, Kychenthal A.
Retina. 2010 Apr;30(4 Suppl):S24-31. doi: 10.1097/IAE.0b013e3181ca1457
53.-
Vitrectomy after intravitreal bevacizumab (Avastin) for retinal detachment in retinopathy of
prematurity.
Kychenthal A, Dorta P.
Retina. 2010 Apr;30(4 Suppl):S32-6. doi:
10.1097/IAE.0b013e3181ca146b.
54.-
25-gauge lens-sparing vitrectomy for stage 4A retinopathy of prematurity. Kychenthal A, Dorta
P.
Retina. 2008 Mar;28(3 Suppl):S65-8. doi:
10.1097/IAE.0b013e318159ec49. Erratum in: Retina. 2009 Jan;29(1):127.
  
|
